Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05026866
Brief Title: A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3)

First Submitted : August 27, 2021
First Submitted that Met QC Criteria : August 27, 2021
First Posted : August 30, 2021

Last Update Submitted that Met QC Criteria : April 19, 2022
Last Update Posted : April 20, 2022